A pooled analysis of the studies found that about two-thirds of participants receiving the drug retatrutide experienced at least a 50% reduction in knee pain, compared with 38% of those receiving a placebo
A pooled analysis of the studies found that about two-thirds of participants receiving the drug retatrutide experienced at least a 50% reduction in knee pain, compared with 38% of those receiving a placebo
<iframe src="https://hindustansphere.com/embed/cluster/3843934caaa7a1432235ea37e0e00acf685361e6" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="Experimental GLP-1 drug demonstrates pain relief in people with osteoarthritis during trials"></iframe>
A pooled analysis of the studies found that about two-thirds of participants receiving the drug retatrutide experienced at least a 50% reduction in knee pain, compared with 38% of those receiving a placebo
